Fellowship · Bellaire, TX
Sponsored by University of Texas Health Science Center at Houston
Dermatofibrosarcoma Protuberans, Version 1.2025, NCCN Clinical Practice Guidelines In Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN · 2025 · 80 citations · Valencia Thomas
Basal Cell Skin Cancer, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN · 2023 · 103 citations · Valencia Thomas
Evidence-Based Clinical Practice Guidelines for Extramammary Paget Disease.
JAMA oncology · 2022 · 123 citations · Valencia Thomas
NCCN Guidelines® Insights: Merkel Cell Carcinoma, Version 1.2024.
Journal of the National Comprehensive Cancer Network : JNCCN · 2024 · 55 citations · Valencia Thomas
Drug Survival of IL-12/23, IL-17 and IL-23 Inhibitors for Psoriasis Treatment: A Retrospective Multi-Country, Multicentric Cohort Study.
American journal of clinical dermatology · 2021 · 102 citations · Karishma Desai
Management of Dermatologic Events Associated With the Nectin-4-directed Antibody-Drug Conjugate Enfortumab Vedotin.
The oncologist · 2022 · 126 citations · Anisha Patel
NCCN Guidelines® Insights: Squamous Cell Skin Cancer, Version 1.2022.
Journal of the National Comprehensive Cancer Network : JNCCN · 2021 · 123 citations · Valencia Thomas
Toxicity in the era of immune checkpoint inhibitor therapy.
Frontiers in immunology · 2024 · 61 citations · Anisha Patel